儿童急性淋巴细胞白血病遗传学异常的临床分析

岳志霞; 李彬; 赵晓曦; 李伟京; 郑胡镛

doi:10.13201/j.issn.1004-2806.2015.03.016

儿童急性淋巴细胞白血病遗传学异常的临床分析

- 首都医科大学附属北京儿童医院血液肿瘤中心(北京, 100045)
基金项目:
北京市医院管理局临床医学发展专项经费资助(No:ZY201404)

详细信息

通讯作者: 郑胡镛,E-mail:zhenghuyong@vip.sina.com

中图分类号: R733.71

收稿日期: 2014-07-24

Clinical analysis of genetic abnormalities in childhood acute lymphoblastic leukemia

More Information

Corresponding author: ZHENG Huyong, E-mail: zhenghuyong@vip.sina.com

Received Date: 24 July 2014

摘要

- 白血病,淋巴细胞,急性 /
- 细胞遗传学 /
- 逆转录聚合酶链反应 /
- 微小残留病
- acute lymphoblastic leukemia /
- cytogenetics /
- reverse transcription polymerase chain reaction /
- mini-mal residual disease

HTML全文

参考文献(15)

[1]	Heng JL,Chen YC,Quah TC,et al.Dedicated cytogenetics factor is critical for improving karyotyping results for childhood leukemia-experience in the National University Hospital,Singapore 1989-2006[J].Ann Acad Med Singapore,2010,39:102-106.
[2]	李志刚,吴敏媛,朱平,等.白血病29种染色体畸变形成的融合基因分析[J].中华儿科杂志,2001,39(11):682-685.
[3]	Cui L,Li Z,Wu M,et al.Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia[J].Leuk Res,2010,34:1314-1319.
[4]	Sandberg AA,Meloni-Ehrig AM.Cytogenetics and genetics of human cancer:methods and accomplishments[J].Cancer Genet Cytogenet,2010,203:102-126.
[5]	Pui CH,Carroll WL,Meshinchi S,et al.Biology,risk stratification,and therapy of pediatric acute leukemias:an update[J].J Clin Oncol,2011,29:551-565.
[6]	Harrison CJ.Acute lymphoblastic leukemia[J].Clin Lab Med,2011,31:631-647.
[7]	Izraeli S,Waldman D.Minimal residual disease in childhood acute lymphoblastic leukemia:current status and challenges[J].Acta Haematol,2004,112:34-39.
[8]	Ryan J,Quinn F,Meunier A,et al.Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches[J].Br J Haematol,2009,144:107-115.
[9]	Madzo J,Zuna J,Muzíková K,et al.Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia:prospective real-time quantitative reverse transcriptase-polymerase chain reaction study[J].Cancer,2003,97:105-113.
[10]	Kato M,Imamura T,Manabe A,et al.Prognostic impact of gained chromosomes in high-hyperdiploid childhood acute lymphoblastic leukaemia:a collaborative retrospective study of the Tokyo Children's Cancer Study Group and Japan Association of Childhood Leukaemia Study[J].Br J Haematol,2014,166:295-298.
[11]	Wieser R.Rearrangements of chromosome band 3q21 in myeloid leukemia[J].Leuk Lymphoma,2002,43:59-65.
[12]	De Braekeleer E,Douet-Guilbert N,Basinko A,et al.Conventional cytogenetics and breakpoint distribution by fluorescent in situ hybridization in patients with malignant hemopathies associated with inv (3)(q21;q26) and t (3;3)(q21;q26)[J].Anticancer Res,2011,31:3441-3448.
[13]	Treaba DO,Chaump M,Merriam P,et al.Unusual blasts with basophilic granules in 2 cases of de novo acute myeloid leukemia with inv3(q21q26.2) and monosomy 7 and coexpression of CD2 and CD31[J].Ann Diagn Pathol,2014,18:33-40.
[14]	Woo JS,Alberti MO,Tirado CA.Childhood B-acute lymphoblastic leukemia:a genetic update[J].Exp Hematol Oncol,2014,3:1-16.
[15]	Iacobucci I,Papayannidis C,Lonetti A,et al.Cytogenetic and molecular predictors of outcome in acute lymphocytic leukemia:recent developments[J].Curr Hematol Malig Rep,2012,7:133-143.